首页>
外国专利>
FORMULATIONS WITH THE WATER-FREE MONONATRIUM SALT OF ALENDRONATE AND THEIR USE FOR THE TREATMENT OF BONE DISEASES
FORMULATIONS WITH THE WATER-FREE MONONATRIUM SALT OF ALENDRONATE AND THEIR USE FOR THE TREATMENT OF BONE DISEASES
展开▼
机译:阿仑膦酸盐无水单钠盐配方及其在治疗骨病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
PCT No. PCT/US96/08284 Sec. 371 Date Dec. 3, 1997 Sec. 102(e) Date Dec. 3, 1997 PCT Filed Jun. 3, 1996 PCT Pub. No. WO96/39149 PCT Pub. Date Dec. 12, 1996Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical dosage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
展开▼